|Assembly Actions - Lowercase
Senate Actions - UPPERCASE
|Jan 08, 2014||referred to health|
|Jan 09, 2013||referred to health|
senate Bill S547
Archive: Last Bill Status - In Senate Committee
- In Committee
- On Floor Calendar
- Passed Senate
- Passed Assembly
- Delivered to Governor
- Signed/Vetoed by Governor
S547 - Details
- Law Section:
- Public Health Law
- Laws Affected:
- Add §3317, Pub Health L; add §19.18, Ment Hyg L
- Versions Introduced in 2011-2012 Legislative Session:
S547 - Sponsor Memo
BILL NUMBER:S547 TITLE OF BILL: An act to amend the public health law and the mental hygiene law, in relation to requiring disclosure of addiction risks for certain prescription drugs PURPOSE: This bill requires disclosure of addiction risks for certain prescription drugs. SUMMARY OF PROVISIONS: Section 1 defines the bill as Michael David Israel patient information act. Section 2 defines opiate analgesics and psychotropic drugs and amends public health law to require that prescribers and pharmacists make patients aware of the risk of addiction and local resources to treat addiction to prescription drugs prior to prescribing or dispensing such drugs. Section 2 also requires that patients sign a waiver stating that they understand the risks of addiction and that they have been provided with information about local resources in the event that they become addicted. In addition section 2 provides a fine scale for failure to
S547 - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 547 2013-2014 Regular Sessions I N S E N A T E (PREFILED) January 9, 2013 ___________ Introduced by Sen. KENNEDY -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law and the mental hygiene law, in relation to requiring disclosure of addiction risks for certain prescription drugs THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. This act shall be known and may be cited as the "Michael David Israel patient information act". S 2. The public health law is amended by adding a new section 3317 to read as follows: S 3317. REQUIRED DISCLOSURES. 1. DEFINITIONS. FOR PURPOSES OF THIS SECTION: (A) "OPIATE ANALGESICS" SHALL MEAN THE MEDICINES BUPRENORPHINE, BUTOR- PHANOL, CODEINE, HYDROCODONE, HYDROMORPHONE, LEVORPHANOL, MEPERIDINE, METHADONE, MORPHINE, NALBUPHINE, OXYCODONE, OXYMORPHONE, PENTAZOCINE AND PROPOXYPHENE AS WELL AS THEIR BRAND NAMES, ISOMERS AND COMBINATIONS. (B) "PSYCHOTROPIC DRUGS SHALL MEAN ANY DRUG OR MEDICINE THAT AFFECTS MENTAL ACTIVITY, BEHAVIOR OR PERCEPTION INCLUDING ANTI-PSYCHOTICS, ANTI- DEPRESSANTS, ANTI-ANXIETY DRUGS OR ANXIOLYTICS AND HYPNOTICS. 2. DISCLOSURES. WHENEVER A PRACTITIONER, PHARMACIST, REGISTERED NURSE OR ANY OTHER PERSON WHO IS AUTHORIZED TO DISTRIBUTE SUBSTANCES REGULATED BY THIS ARTICLE, DISPENSES OPIATE ANALGESICS OR PSYCHOTROPIC DRUGS SUCH PRESCRIBING PHYSICIAN, NURSE OR PHARMACIST SHALL: (A) DESCRIBE THE RISKS OF ADDICTION TO THE PATIENT; (B) AFTER CONSULTING THE PATIENT'S MEDICAL HISTORY, INFORM THE PATIENT OF HIS OR HER CHANCE OF ADDICTION; (C) PROVIDE THE PATIENT WITH INFORMATION ABOUT COPING WITH OPIATE ANALGESIC OR PYSCHOTROPIC DRUG ADDICTION AND AVAILABLE LOCAL RESOURCES INCLUDING DETOXIFICATION CENTERS, COUNSELING SERVICES AND HOTLINES; AND EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted.
Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.
By contributing or voting you agree to the Terms of Participation and verify you are over 13.